Metagenomi, Inc.
MGX
$1.67
$0.159.87%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -78.06M | -73.95M | -75.00M | -77.27M | -68.26M |
| Total Depreciation and Amortization | 5.41M | 5.15M | 4.94M | 4.64M | 4.21M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 23.25M | 14.00M | 12.56M | 4.73M | -932.00K |
| Change in Net Operating Assets | -59.67M | -48.59M | -42.98M | -32.36M | -26.43M |
| Cash from Operations | -109.07M | -103.39M | -100.48M | -100.26M | -91.41M |
| Capital Expenditure | -3.11M | -4.52M | -5.58M | -8.06M | -9.81M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -85.04M | -51.55M | 34.33M | 31.13M | 55.55M |
| Cash from Investing | -88.16M | -56.07M | 28.75M | 23.07M | 45.73M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 86.54M | 86.54M | 86.54M | 86.54M | -- |
| Repurchase of Common Stock | -2.52M | -2.52M | -2.03M | -- | -- |
| Issuance of Preferred Stock | -- | 0.00 | 0.00 | 0.00 | 4.30M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -1.33M | -3.24M | -3.28M | -3.28M |
| Cash from Financing | 84.01M | 82.68M | 81.26M | 83.25M | 1.01M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -113.22M | -76.78M | 9.53M | 6.06M | -44.66M |